Pure Global

The Effect of Emotional Freedom Technique and Virtual Reality Glasses on Anxiety and Vital Signs - Trial NCT06384274

Access comprehensive clinical trial information for NCT06384274 through Pure Global AI's free database. This phase not specified trial is sponsored by Necmettin Erbakan University and is currently Not yet recruiting. The study focuses on Anxiety. Target enrollment is 75 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06384274
Not yet recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06384274
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
The Effect of Emotional Freedom Technique and Virtual Reality Glasses on Anxiety and Vital Signs
The Effect of Emotional Freedom Technique and Virtual Reality Glasses on Anxiety and Vital Signs in Individuals Receiving Hyperbaric Oxygen Therapy: Randomized Controlled Trials

Study Focus

Anxiety

Emotional Freedom Technique

Interventional

other

Sponsor & Location

Necmettin Erbakan University

Konya, Turkey

Timeline & Enrollment

N/A

Oct 01, 2024

Jun 01, 2025

75 participants

Primary Outcome

State Anxiety Inventory (STAI)

Summary

The aim of the study was to examine the effects of the emotional freedom technique and
 virtual reality glasses applied to individuals receiving hyperbaric oxygen therapy for the
 first time on anxiety and vital signs. The hypotheses of this research are that there is a
 difference between the emotional liberation technique and virtual reality glasses groups and
 the control group in terms of anxiety and vital signs.

ICD-10 Classifications

Anxiety disorder, unspecified
Other anxiety disorders
Phobic anxiety disorders
Phobic anxiety disorder, unspecified
Generalized anxiety disorder

Data Source

ClinicalTrials.gov

NCT06384274

Non-Device Trial